Kathleen Wesa, MD
Sloan-Kettering Institute for Cancer Research
Clinical Title: Vitamin D Levels in Stage IV Colorectal Cancer Patients: A Phase II Study
Description: Determine if it is clinically possible to achieve and maintain normal serum Vitamin D levels in patients with metastatic colon cancer on front-line treatment.
The purpose of this study is to find out what effects, good and/or bad, vitamin D blood levels has on stage IV colorectal cancer. Tbe doctors want to see if it is possible to increase low vitamin D levels into normal range using vitamin D supplements taken by mouth. Low vitamin D levels have been associated with worse outcomes in persons who have cancer. Low vitamin D may also cause people to have symptoms such as pain and fatigue. We want to see if increasing low vitamin D levels will help improve cancer outcomes. Vitamin D is routinely repleted in all subjects known to be vitamin D deficient. Therefore, the treatment given would be considered standard of care.
Status: Active Trial
Accepting Patients? No
NIH Clinical Trial Link: http://clinicaltrials.gov/ct2/show/NCT01074216?term=kathleen+wesa&rank=2« Back to Funded Clinical Trials
1,500 American people died today from cancer.
1,500 more will die tomorrow and the next day and the next...
Demanding it all!
Funding innovative cancer research for
Treatments. Cures. Life.